notori
reput
influenza
virus
deriv
abil
frequent
alter
key
featur
antigen
characterist
amino
acid
chang
critic
site
hemagglutinin
molecul
creat
new
antigen
variant
may
escap
recognit
antibodi
acquir
previou
infect
phenomenon
call
antigen
drift
main
reason
need
frequent
updat
virus
includ
season
influenza
vaccin
provid
appropri
protect
influenza
addit
segment
natur
influenza
viru
genom
allow
exchang
entir
gene
segment
event
differ
influenza
virus
simultan
infect
replic
host
cell
process
known
genet
reassort
result
antigen
shift
reassort
event
frequent
seen
aquat
bird
main
reservoir
influenza
virus
well
pig
mammalian
speci
suscept
avian
human
influenza
year
sinc
influenza
viru
subtyp
cocircul
influenza
b
virus
human
popul
virus
undergon
signific
evolut
antigen
drift
occasion
anim
influenza
viru
reassort
influenza
viru
may
caus
infect
human
contact
infect
viru
readili
replic
human
viru
acquir
abil
spread
human
human
absenc
immun
larg
segment
human
popul
viru
may
caus
global
pandem
although
influenza
pandem
obvious
stricken
human
throughout
histori
first
convinc
histor
evid
influenza
pandem
late
centuri
addit
influenza
pandem
identifi
accur
clinic
epidemiolog
descript
histor
precis
laboratori
evid
avail
pandem
occur
memori
devast
impact
spanish
flu
pandem
still
vividli
present
mind
medic
scientif
expert
well
public
first
experi
influenza
vaccin
undertaken
year
first
human
influenza
virus
grow
understand
annual
influenza
epidem
contribut
signific
morbid
mortal
popul
fear
anoth
sever
pandem
stimul
vaccin
research
earli
techniqu
isol
influenza
virus
embryon
hen
egg
refin
open
door
systemat
larger
vaccin
trial
year
descend
influenza
virus
swept
world
continu
cocircul
influenza
b
virus
caus
annual
epidem
vari
sever
earli
vaccin
trial
show
promis
result
result
approv
first
influenza
vaccin
unit
state
unit
nation
assign
interim
commiss
task
develop
initi
program
establish
world
health
organ
session
interim
commiss
earli
public
health
threat
pose
influenza
discuss
decid
form
special
committe
influenza
order
work
guidelin
influenza
surveil
coincident
observ
season
vaccin
use
militari
popul
unit
state
provid
signific
protect
epidem
character
circul
viru
hemagglutin
inhibit
hi
test
reveal
signific
antigen
differ
vaccin
viru
epidem
viru
shed
light
rapid
evolut
influenza
virus
establish
need
ongo
global
influenza
surveil
season
pandem
influenza
virus
within
short
time
dr
ch
andrew
unit
kingdom
summar
view
influenza
expert
group
guidelin
submit
interim
commiss
interim
commiss
accept
suggest
plan
first
step
decid
establish
financ
world
influenza
center
auspic
medic
research
council
unit
kingdom
import
decis
nowaday
regard
birth
global
influenza
thu
celebr
anniversari
leadership
dr
andrew
world
influenza
center
immedi
start
collect
inform
influenza
refin
method
studi
viru
train
scientist
use
method
establish
contact
laboratori
number
countri
level
influenza
surveil
alreadi
exist
begin
establish
influenza
network
third
execut
board
meet
held
request
health
administr
member
state
provid
inform
includ
data
clinic
impact
influenza
morbid
mortal
intellig
public
health
measur
taken
countri
confer
copenhagen
oper
influenza
network
leadership
discuss
need
intern
coordin
influenza
research
recogn
main
item
expert
committe
influenza
address
identifi
expert
committe
conven
geneva
septemb
meet
present
begin
influenza
surveil
network
today
known
global
influenza
surveil
respons
system
month
later
expert
committe
publish
first
report
includ
laboratori
techniqu
design
influenza
viru
strain
inform
avail
vaccin
therapeut
measur
epidemiolog
surveil
method
guidelin
train
laboratori
year
bulletin
devot
entir
issu
influenza
underlin
import
common
year
increas
understand
health
burden
caus
influenza
virus
widen
insight
biolog
virus
antigen
divers
reinforc
need
systemat
surveil
global
circul
influenza
virus
mount
appropri
time
respons
season
pandem
influenza
gisr
establish
countri
alreadi
influenza
surveil
place
abl
report
data
contribut
laboratori
countri
later
recogn
nation
influenza
center
nic
countri
american
european
region
african
region
laboratori
eastern
mediterranean
asian
western
pacif
region
one
first
year
gisr
number
nic
increas
end
second
decad
number
increas
collabor
centr
surveil
epidemiolog
control
influenza
atlanta
formal
recogn
serv
influenza
refer
center
togeth
world
influenza
center
london
five
year
establish
network
face
first
major
challeng
pandem
caus
influenza
viru
subtyp
earli
may
nic
singapor
inform
identifi
influenza
viru
antigen
distinct
influenza
virus
circul
previou
viru
soon
character
classifi
new
subtyp
influenza
virus
new
pandem
viru
rapidli
spread
via
transport
rout
land
sea
epidem
start
harbor
citi
number
countri
pandem
viru
form
reagent
specif
identif
new
viru
distribut
network
nic
diagnost
reagent
vaccin
could
produc
soon
begin
pandem
previous
circul
influenza
disappear
human
popul
pandem
follow
year
primari
method
detect
viru
isol
embryon
hen
egg
less
common
experiment
anim
growth
viru
verifi
hemadsorpt
virus
identifi
use
hi
test
hi
test
well
test
use
measur
antibodi
human
sera
valu
global
influenza
program
newli
establish
surveil
network
recogn
wide
period
result
continu
effort
extend
network
area
countri
influenza
surveil
yet
well
establish
influenza
virus
circul
year
replac
influenza
viru
caus
pandem
viru
first
identifi
nic
hong
kong
recogn
differ
antigen
properti
influenza
virus
still
circul
simultan
pandem
viru
earli
phase
pandem
hong
kong
nic
swiftli
sent
new
viru
world
influenza
center
london
character
classifi
influenza
viru
novel
viru
spread
australia
asia
august
septemb
unit
state
epidem
reach
peak
decemb
took
anoth
year
major
epidem
activ
caus
new
pandem
viru
note
europ
collabor
center
london
atlanta
distribut
novel
viru
vaccin
manufactur
pandem
subsequ
year
influenza
virus
mainli
propag
embryon
hen
egg
laboratori
also
use
primari
monkey
kidney
cell
viru
propag
method
visual
immunofluoresc
stain
respiratori
epitheli
cell
clinic
specimen
earli
stage
develop
restrict
special
laboratori
quantit
specif
antibodi
sera
hi
test
remain
method
choic
laboratori
investig
reveal
pandem
virus
product
genet
reassort
novel
pandem
virus
acquir
gene
segment
avian
influenza
viru
remain
segment
previous
circul
human
influenza
viru
find
shed
light
import
influenza
virus
circul
anim
reservoir
particularli
aquat
fowl
pig
year
influenza
surveil
wild
bird
reveal
signific
number
antigen
distinct
influenza
subtyp
surveil
human
suggest
human
infect
anim
influenza
virus
rare
possibl
underdiagnos
event
two
pandem
year
apart
consider
challeng
gisr
pandem
network
play
central
role
viru
identif
gather
crucial
inform
spread
virus
impact
pandem
differ
countri
collabor
within
network
intensifi
mani
laboratori
improv
technic
capabl
decad
qualiti
influenza
vaccin
improv
use
increas
predominantli
industri
countri
start
pandem
held
annual
consult
expert
make
recommend
influenza
virus
includ
vaccin
follow
season
first
year
recommend
one
influenza
viru
one
influenza
b
viru
figur
addit
improv
vaccin
us
food
drug
administr
fda
licens
amantadin
hydrochlorid
prevent
treatment
infect
caus
influenza
virus
subtyp
emerg
subtyp
licensur
revok
time
drug
action
novel
viru
proven
gisr
network
continu
grow
end
recogn
nic
african
american
eastern
mediterranean
european
asian
western
pacif
region
import
anim
influenza
virus
pandem
threat
human
broadli
accept
consequ
design
influenza
laboratori
st
jude
children
research
hospit
memphi
collabor
center
studi
ecolog
influenza
anim
long
period
laboratori
conduct
groundbreak
research
biolog
divers
influenza
virus
aquat
bird
distribut
virus
bird
migrat
disappear
human
popul
pandem
influenza
virus
antigen
close
relat
virus
circul
late
earli
unexpectedli
caus
signific
outbreak
china
may
russia
viru
rapidli
spread
differ
part
world
affect
predominantli
younger
person
born
lack
preexist
immun
subtyp
contrast
pandem
virus
viru
prevent
influenza
virus
continu
circul
rather
subtyp
influenza
virus
cocircul
influenza
b
virus
mani
year
consequ
gisr
laboratori
ad
surveil
virus
requir
task
recommend
inclus
viru
influenza
vaccin
season
thereaft
decad
interest
new
laboratori
method
develop
primari
monkey
kidney
cell
although
highli
sensit
isol
varieti
virus
includ
influenza
virus
becam
restrict
special
laboratori
continu
line
dog
kidney
cell
becam
use
method
develop
allow
specif
diagnosi
influenza
infect
within
hour
arriv
clinic
sampl
laboratori
initi
exfoli
cell
clinic
specimen
fix
microscop
slide
stain
antibodi
progress
anim
sera
mous
monoclon
antibodi
made
techniqu
reliabl
unambigu
yet
still
requir
experienc
person
read
slide
subsequ
develop
yield
numer
output
less
thu
allow
simultan
test
larger
number
clinic
specimen
differ
format
immunoassay
also
develop
detect
antibodi
human
sera
modern
techniqu
rapidli
adopt
mani
laboratori
gisr
advanc
enhanc
global
influenza
surveil
specimen
could
analyz
greater
detail
nic
collabor
center
hand
laboratori
use
techniqu
replac
viru
cultur
egg
cell
cultur
effect
reduc
number
influenza
viru
isol
countri
molecular
biolog
open
unforeseen
opportun
intensifi
analysi
character
influenza
virus
revers
transcript
clone
sequenc
influenza
viru
gene
revolution
understand
influenza
viru
evolut
pathogen
epidemiolog
scientist
special
gisr
laboratori
quickli
understood
enorm
valu
techniqu
began
integr
process
character
virus
importantli
late
network
began
use
sequenc
data
hemagglutinin
adjunct
antigen
data
select
virus
recommend
inclus
season
vaccin
diverg
influenza
b
virus
victoria
yamagata
lineag
first
report
research
collabor
center
atlanta
collabor
colleagu
japanes
nic
tokyo
lineag
like
cocircul
sever
year
scientif
evid
obtain
influenza
season
influenza
b
virus
distinct
reaction
pattern
hi
test
detect
nucleotid
sequenc
analys
confirm
genet
divers
equal
import
scientif
breakthrough
gener
influenza
research
diagnost
surveil
invent
polymeras
chain
reaction
pcr
origin
public
describ
techniqu
appear
januari
year
later
scientist
publish
applic
techniqu
detect
influenza
time
write
pubm
search
influenza
pcr
yield
citat
among
first
public
scientist
gisr
nowaday
nucleotid
sequenc
analys
sever
influenza
viru
gene
amplifi
pcr
form
central
part
work
done
gisr
laboratori
particularli
collabor
center
lead
biannual
recommend
composit
season
influenza
vaccin
figur
show
number
virus
sequenc
data
avail
gisaid
databas
end
period
number
nic
grown
collabor
center
studi
ecolog
influenza
anim
memphi
collabor
center
refer
research
influenza
melbourn
join
group
previous
collabor
center
london
atlanta
year
pandem
influenza
commun
public
health
expert
agre
question
whether
rather
next
pandem
happen
thought
catalyz
nation
intern
activ
toward
better
prepared
event
influenza
pandem
earli
accumul
data
reveal
death
toll
spanish
flu
pandem
significantli
higher
assum
previous
light
new
estim
mortal
better
understand
evolut
ecolog
influenza
scientif
commun
conclud
similarli
devast
influenza
pandem
futur
could
exclud
sever
countri
group
expert
differ
field
includ
scientist
gisr
laboratori
start
develop
strategi
help
minim
public
health
socioeconom
effect
futur
pandem
world
health
organ
encourag
countri
elabor
control
measur
pandem
event
establish
nation
pandem
prepared
plan
event
made
clear
everi
countri
serious
prepar
possibl
pandem
hong
kong
nic
receiv
clinic
specimen
child
fatal
respiratori
ill
larg
outbreak
avian
influenza
poultri
hong
kong
sar
china
specimen
posit
influenza
subtyp
could
identifi
avail
reagent
agre
within
gisr
viru
andor
origin
clinic
specimen
immedi
sent
one
collabor
center
laboratori
extens
collect
reagent
sophist
techniqu
nic
hong
kong
sent
viru
nic
netherland
collabor
center
atlanta
london
memphi
laboratori
character
viru
highli
pathogen
avian
influenza
viru
subtyp
demonstr
viru
aros
numer
reassort
event
differ
wild
bird
later
year
addit
human
infect
viru
record
hong
kong
sar
china
patient
infect
lethal
outbreak
eventu
curtail
cull
poultri
establish
rest
day
live
bird
market
would
close
clean
intens
live
bird
market
surveil
hong
kong
first
time
avian
influenza
viru
conclus
document
caus
sever
sever
human
case
within
short
period
event
intensifi
countri
effort
develop
better
pandem
prepared
plan
year
brought
sever
critic
challeng
gisr
network
reappear
avian
influenza
viru
human
hiatu
extens
outbreak
avian
influenza
poultri
farm
netherland
adjac
countri
numer
associ
mostli
mild
human
case
outbreak
sever
acut
respiratori
syndrom
coronaviru
start
southern
china
rapidli
spread
mani
gisr
laboratori
forefront
identif
character
virus
design
control
measur
nic
quickli
provid
reagent
instruct
specif
detect
virus
clinic
sampl
pcr
method
choic
period
gisr
network
coordin
support
gip
demonstr
impress
flexibl
address
public
health
threat
influenza
respiratori
virus
sinc
time
avian
influenza
virus
sever
subtyp
continu
caus
human
infect
certain
part
world
pose
continu
pandem
threat
special
note
avian
virus
caus
human
case
late
connect
larg
outbreak
backyard
poultri
industri
poultri
farm
sever
countri
asia
migrat
bird
viru
rapidli
spread
countri
asia
later
area
world
includ
africa
europ
number
human
case
caus
viru
rapidli
increas
time
write
human
case
report
rate
gisr
laboratori
support
rapidli
gear
address
novel
threat
surveil
diagnost
capac
built
mani
countri
area
thu
far
lack
abil
need
rapid
share
virus
detail
character
expert
laboratori
eventu
vaccin
product
recogn
also
accept
countri
provid
virus
equit
time
access
benefit
notabl
pandem
influenza
vaccin
could
develop
result
viru
share
evolv
exemplari
intern
instrument
pip
framework
unanim
adopt
member
state
world
health
assembl
year
prior
ratif
pip
framework
global
initi
share
influenza
data
launch
world
health
assembl
data
share
platform
provid
complet
collect
influenza
viru
sequenc
data
well
clinic
epidemiolog
inform
virus
studi
databas
wide
use
gisr
laboratori
upload
sequenc
data
import
resourc
compil
phylogenet
epidemiolog
new
class
medicin
neuraminidas
inhibitor
came
clinic
use
essenti
almost
circul
human
influenza
virus
becam
resist
adamantan
demonstr
larg
studi
collabor
center
howev
long
influenza
virus
also
becam
resist
group
neuraminidas
inhibitor
first
recogn
nic
norway
test
antivir
resist
thu
becam
routin
need
gisr
laboratori
group
technic
expert
auspic
regularli
updat
protocol
pcr
techniqu
antivir
resist
test
focu
pandem
plan
mani
countri
threat
highli
pathogen
avian
influenza
emerg
asia
came
surpris
new
antigen
variant
alreadi
circul
influenza
subtyp
caus
next
pandem
viru
first
detect
rapidli
character
collabor
center
atlanta
receiv
specimen
first
american
patient
infect
viru
respons
find
collabor
center
atlanta
rapidli
develop
kit
diagnost
reagent
dispatch
kit
nic
around
world
within
week
viru
spread
mani
countri
differ
contin
spread
track
global
gip
pandem
mind
year
lead
pandem
countri
prepar
pandem
sever
morbid
mortal
luckili
impact
pandem
much
less
sever
expect
compar
averag
influenza
season
subsequ
gip
assist
countri
adjust
prepared
measur
varieti
pandem
scenario
publish
updat
prepared
plan
along
checklist
countri
consid
differ
scenario
prepar
step
also
take
experi
pandem
year
exist
gisr
grown
includ
nic
figur
collabor
center
essenti
regulatori
laboratori
refer
laboratori
recogn
import
countri
asia
oceania
emerg
new
antigen
variant
zoonot
transmiss
influenza
virus
present
need
establish
addit
collabor
center
collabor
center
melbourn
design
one
tokyo
center
beij
gisr
becom
uniqu
network
laboratori
test
approxim
million
clinic
sampl
per
year
report
sever
hundr
thousand
result
provid
thousand
influenza
virus
collabor
center
thorough
character
done
deliv
one
main
product
network
suitabl
virus
inclus
season
pandem
vaccin
gisr
commun
close
collabor
scientist
academia
pharmaceut
industri
influenza
perceiv
import
public
health
problem
scientist
also
public
decis
maker
mani
countri
public
press
reli
inform
provid
member
gisr
network
collabor
center
mani
nic
frequent
host
staff
gisr
laboratori
train
joint
scientif
project
addit
establish
essenti
tool
commun
gisr
laboratori
exampl
flunet
platform
electron
databas
gisr
laboratori
upload
laboratori
epidemiolog
data
launch
year
ago
particularli
week
month
lead
biannual
vaccin
consult
meet
collabor
center
exchang
virus
reagent
vast
amount
inform
vaccin
consult
meet
held
year
sinc
meet
held
twice
year
februari
meet
recommend
made
northern
hemispher
august
southern
hemispher
respect
switch
annual
vaccin
consult
meet
intensifi
collabor
gisr
partner
allow
industri
produc
accur
vaccin
match
need
northern
hemispher
southern
hemispher
sinc
incept
gisr
countless
enthusiast
wide
respect
scientist
support
technic
administr
staff
ensur
success
highli
collabor
etho
ongo
technic
develop
geograph
expans
addit
region
global
meet
gisr
laboratori
organ
substanti
foster
dissemin
import
inform
provid
excel
opportun
establish
reinforc
contact
member
gisr
commun
partner
highli
develop
influenza
surveil
network
commend
intern
polit
bodi
nation
author
busi
recent
meet
nic
held
geneva
juli
commemor
anniversari
gisr
review
past
reflect
present
situat
examin
take
network
forward
futur
excit
scientif
achiev
technic
develop
requir
meet
new
influenza
threat
one
hundr
year
pandem
understand
influenza
pandem
strike
unpredict
time
gisr
network
must
remain
alert
time
recogn
potenti
threat
provid
world
tool
minim
impact
influenza
epidem
pandem
author
wish
thank
maja
luka
schemper
reynald
erard
claudia
pire
mari
villemin
provid
invalu
materi
archiv
